RECLAST

Trials studying RECLAST

• phase3Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Boneterminatedn=11
• phase2Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasisrecruitingn=152
• phase3Effects of Romosozumab on Bone Density in Women With Anorexia Nervosacompletedn=30
• phase2Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcomacompletedn=7
• phase3Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcomaactive not recruitingn=318
• phase1Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancercompletedn=29
• —Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosiscompletedn=2,881
• phase2Bisphosphonates for Prevention of Post-Denosumab Bone Losscompletedn=24